Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H SPENCER

Showing results (571-580 of 615) with videos related to

Pageof 62
Sort By:
Haematologica|October 21, 2021
Tumor suppressor function of <i>WT1</i> in acute promyelocytic leukemiaMatthew J Christopher, Casey D S Katerndahl, Hayley R LeBlanc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2024
Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote LeukemogenesisNancy B J Arthur, Keegan A Christensen, Kathleen Mannino, et al.
Haematologica|April 15, 2024
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromesAgata Gruszczynska, Abhishek Maiti, Christopher A Miller, et al.
Annals of the Rheumatic Diseases|October 24, 2015
Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositisKatherine E Lintner, Anjali Patwardhan, Lisa G Rider, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Arthritis Research & Therapy|February 1, 2018
Age and fecal microbial strain-specific differences in patients with spondyloarthritisMatthew L Stoll, Pamela F Weiss, Jennifer E Weiss, et al.
Blood Cancer Journal|August 13, 2025
Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editingClément Collignon, Tucker Hansen, Colin Hercus, et al.
Blood|January 9, 2013
Genomic impact of transient low-dose decitabine treatment on primary AML cellsJeffery M Klco, David H Spencer, Tamara L Lamprecht, et al.
Leukemia|February 16, 2023
KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stressNancy Issa, Hassan Bjeije, Elisabeth R Wilson, et al.
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Pageof 62

Showing results (571-580 of 615) with videos related to

Sort By:
Pageof 62
Haematologica|October 21, 2021
Tumor suppressor function of <i>WT1</i> in acute promyelocytic leukemiaMatthew J Christopher, Casey D S Katerndahl, Hayley R LeBlanc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2024
Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote LeukemogenesisNancy B J Arthur, Keegan A Christensen, Kathleen Mannino, et al.
Haematologica|April 15, 2024
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromesAgata Gruszczynska, Abhishek Maiti, Christopher A Miller, et al.
Annals of the Rheumatic Diseases|October 24, 2015
Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositisKatherine E Lintner, Anjali Patwardhan, Lisa G Rider, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Arthritis Research & Therapy|February 1, 2018
Age and fecal microbial strain-specific differences in patients with spondyloarthritisMatthew L Stoll, Pamela F Weiss, Jennifer E Weiss, et al.
Blood Cancer Journal|August 13, 2025
Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editingClément Collignon, Tucker Hansen, Colin Hercus, et al.
Blood|January 9, 2013
Genomic impact of transient low-dose decitabine treatment on primary AML cellsJeffery M Klco, David H Spencer, Tamara L Lamprecht, et al.
Leukemia|February 16, 2023
KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stressNancy Issa, Hassan Bjeije, Elisabeth R Wilson, et al.
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Pageof 62